Evolva completes share sale related to Allylix acquisition

SIX Swiss Exchange based in Zurich
SIX Swiss Exchange based in Zurich

Evolva Holding SA has completed the placing of all shares earmarked to satisfy certain liabilities and transaction expenses related to the Allylix acquisition, a privately held yeast fermentation company with a focus on high-value ingredients, as announced on 16 December 2014. A total of 6.1 million shares were sold between 16 and 19 December. One Swiss investment fund acquired a block of five million shares. The transaction has no impact on the number of outstanding Evolva shares.

Continue reading